Professor Noemi Lois awarded Edinburgh King James IV Professorship by The Royal College of Surgeons

News
Article

Professor Lois accepted the award at the Royal College of Ophthalmologists Annual Congress

Professor Noemi Lois. Image courtesy of Queen's University Belfast.

Professor Noemi Lois was specifically recognised for her work on the DIAMONDS clinical trial. Image courtesy of Queen's University Belfast.

At the 2024 Royal College of Ophthalmologists (RCOphth) Annual Congress, Noemi Lois, MD, PhD, FRCS(Ed), FRCOphth, was awarded The Royal College of Surgeons of Edinburgh King James IV Professorship. She is Professor of Ophthalmology at Queen’s University Belfast, where she leads a preclinical and clinical research programme focused on diabetic retinopathy.1 In a news release, the award was described as the most senior academic award made by the College. Professor Lois was honoured for her many contributions to retinal surgery, specifically as chief investigator of the Diabetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS) multicentre clinical trial.

"I am thoroughly delighted to receive this very precious award, which means a lot to me,” Professor Lois said in the news release.1 “The Royal College of Surgeons of Edinburgh generously funded a great deal of experimental research I undertook while a full time Consultant Ophthalmologist in Aberdeen and I will be always indebted to them for their support.”

Professor Lois joined Queen’s University Belfast in 2013, where she is a Clinical Professor of Ophthalmology in the Wellcome-Wolfson Institute for Experimental Medicine. She is also an Honorary Consultant Ophthalmologist and Vitreoretinal Surgeon at the Belfast Health and Social Care Trust.

The DIAMONDS trial, funded by the National Institute for Health and Care Research, recruited 266 UK participants with diabetic macular oedema (DME). Patients were treated with a novel macular laser treatment, subthreshold micropulse macular laser. The treatment was found to be as effective as standard macular lasers for preserving sight in patients with DME. Professor Lois is also leading a large clinical trial which aims to introduce a new alternative technique for monitoring DME and proliferative diabetic retinopathy.2

References


1. Queen’s academic awarded prestigious Professorship. News release. Queen's University Belfast. Published 21 May, 2024. Accessed 22 May, 2024. https://www.qub.ac.uk/News/Allnews/2024/QueensacademicawardedprestigiousProfessorship.html
2. Professor Noemi Lois, Clinical Professor of Ophthalmology. Queen's University Belfast. Accessed 22 May, 2024. https://www.qub.ac.uk/News/find-an-expert/ProfessorNoemiLois.html

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.